This report aims to provide detailed insights into the Neuromodulation Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Expected Revenue Growth Analysis:
The neuromodulation market is projected to grow at a CAGR of 8.6% during the forecast period to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921
Key Factors Driving Market Growth:
The Factors such as the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders are driving neuromodulation market growth.
The internal neuromodulation segment accounted for the largest share of the Neuromodulation Market.
Based on technology, the neuromodulation is segmented into internal neuromodulation and external neuromodulation. The internal neuromodulation segment accounted for the largest share of the spinal cord stimulation market in 2019. This can be attributed to the benefits of internal neuromodulation technologies, such as reductions in post-surgical complications and length of hospital stay, as well as long-term cost savings associated with the use of internal neuromodulation devices.
The transcutaneous electrical nerve stimulation segment accounted for the largest share of the External Neuromodulation in 2019.
Based on type, the External Neuromodulation is segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). TENS accounted for the largest share of spinal cord stimulation market in 2019. This is mainly due to the higher incidence of chronic disorders, the wide range of applications of these devices, their cost-effectiveness, and the rising demand for non-invasive therapy.
North America to dominate the Neuromodulation Market during the forecast period
In 2019, North America dominated the market, followed by Europe. The major factors driving the growth of spinal cord stimulation market include the rising prevalence of chronic diseases, the increasing geriatric population, and the rising number of cases of Lyme and Alzheimer's disease.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=921
The prominent players in this market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), and LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel).
Medtronic (Ireland) dominated the global neuromodulation market. The company’s leading position can be attributed to its wide portfolio of neuromodulation devices and a strong geographical footprint. The company operates in the US, Europe, and the Asia Pacific. It serves clinicians, physicians, hospitals, and patients in more than 160 countries. R&D is a key area of focus for Medtronic—it invested USD 2,330 million in 2019, as compared to USD 2,256 million in 2018 and USD 2,193 million in 2017. The company focuses on organic as well as inorganic growth strategies to gain a competitive edge.
Recent Developments:
1. In 2019, NeuroSigma signed a partnership agreement with Teijin Limited (Teijin) (Japan). The partnership granted Teijin Pharma, the core company of Teijin’s healthcare business, exclusive rights to market NeuroSigma’s Monarch eTNS system in Japan, as well as the company’s TNS patent rights in Japan related to the non-invasive treatment of ADHD.
2. In 2018, Abbott signed an agreement with the National Institutes of Health (NIH) (US). As per the agreement, Abbott will provide neuromodulation technologies, including directional DBS, SCS, and DRG therapy, for NIH research to explore their applications in chronic pain and progressive movement disorders.
3. In 2017, Medtronic signed a partnership agreement with Mercy (US) to establish a new data sharing and analysis network that helps gather clinical evidence for medical device innovation and patient access
Neuromodulation Market : Rising Prevalence of Neurological Disorders
Fight the struggles with your healthcare-related marketing campaigns with one robust database; the Medical Records Director Email List.
Respond to your market's demands instantly, with a readily available Medical Records Director Mailing List, enabling a market reach like never before.
Beat the competition in the healthcare sector with precision and through HealthExeData's on-point marketing email list.
Global Nerve Repair and Regeneration Market ReportThe ‘Global Nerve Repair and Regeneration Market Insights, Forecast to 2026’ offers a comprehensive evaluation of the Nerve Repair and Regeneration market on the global scale and sheds light on the growth opportunities and prospects to help readers formulate strategic plans.
The report offers information on the overall market trends and analyzes historical data to offer accurate forecast estimations.
The report assesses the impact of the COVID-19 pandemic on the Nerve Repair and Regeneration market and key segments.
The report also studies the impact of the COVID-19 pandemic on the global supply chains and economic scenario of the industry.
It considers the COVID-19 pandemic as a key factor influencing the growth of the Nerve Repair and Regeneration market.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1733Key Manufacturers in the Global Nerve Repair and Regeneration Market:AxoGen Inc., Baxter International Inc., Boston Scientific Corporation, Livanova PLC (Cyberonics Inc.), Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Integra Lifesciences Holding Corporation, Orthod Group Ltd., Polyganics B.V., Stryker Corporation, Cyberonics Inc.The report offers an in-depth analysis of the value chain, upstream and downstream factors, sales network and distribution channels, growth trends, driving and restraining factors, developments, production and consumption pattern, end-users, and regional bifurcation.
The report also provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data.Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1733The report for the Nerve Repair and Regeneration market is formulated through the segmentation and sub-segmentation of the market to offer a better understanding of the market.
The polymer market is expected to progress at a 5.1% CAGR during the forecast period (2020–2030) owing to the increasing substitution of conventional materials in the automotive industry with lighter alternatives and escalating use of smart polymers in the healthcare sector.
Additionally, polymers are also used in large quantities in the packaging and electronics industries.
These drivers will, therefore, help the market grow from $533.6 billion in 2019 to $838.5 billion by 2030.The growing preference for lightweight materials in the automobile and other manufacturing industries will play a vital role in the polymer market growth.
These sectors are using polymers as a substitute for conventional materials like metals and ceramics, as the former have excellent electrical, chemical, and mechanical properties, such as corrosion resistance, elasticity, high strength-to-weight ratio, and insulating and optical properties.
Moreover, it is estimated that a nearly 10% reduction in vehicle weight causes a proportional reduction in fuel consumption.Another key factor accelerating the polymer market growth is the increasing usage of smart polymers in the healthcare industry.
The mushrooming demand for hydrogels (for targeted drug delivery), biosensors, and artificial body parts will fuel the demand for such polymers in the coming years.
Buddhi Clinic is best Brain Mapping Nerve Conduction Centre in Chennai.
Our Neurologists diagnosing, treating, and managing disorders of the brain and nervous system.Brain Mapping Labs in Chennai
Neuromodulation Market is valued around USD 4.89 Billion in 2019 and expected to reach USD 20.08 Billion by 2030 with the CAGR of 13.7% over the forecast period.Neuromodulation is a procedure which requires the implantation of electrodes directly to peripheral nerves or brain & pulse generator under skin.
This helps to provide the electrical impulses which helps in the treatment of various neurological disorders such as epilepsy, pain management, tremor and many more.
Based upon technology, the neuromodulation market is fragmented into internal neuromodulation and external neuromodulation.
Based on The regional bifurcation of countries includes North America, Europe, Asia-Pacific, and RoW which are further segmented into major countries such as U.S., UK, France, and others.The neuromodulation market is mainly driven by the high prevalence of various neurological disorders followed by the presence of large geriatric population.
There has been constant expansion of application in the treatment of various disorders followed by the growing demand for effective pain management therapies owing to growth in surgeries, trauma cases & many more.
However, high cost of the Neurostimulators along with the lack of skilled professionals trained in neuromodulation therapy is likely to inhibit the market growth during forecast period.Download sample copy of this report at https://www.nextmsc.com/Neuromodulation-Market/request-sampleThe developed regions such as North America and Europe are expected to hold the major market share owing to the presence of major market players in the region along with technological advancement.
The Global Neuromodulation Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on technology and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Neuromodulation Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/16700-neuromodulation-devices-market-reportThe report also covers the complete competitive landscape of the global Neuromodulation Devices market with company profiles of key players such as:Biocontrol MedicalBoston Scientific CorporationCyberonics, Inc.Medtronic, Inc.Neuronetics, Inc.Neuropace, Inc.Neurosigma, Inc.Nevro CorporationST.
Jude Medical, Inc.Synapse Biomedical, Inc.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Technology:Internal NeuromodulationSpinal Cord Stimulation (SCS)Deep Brain Stimulation (DBS)Vagus Nerve Stimulation (VNS)Sacral Nerve Stimulation (SNS)Gastric Electrical Stimulation (GES)External NeuromodulationTranscutaneous Electrical Nerve Stimulation (Tens)Transcranial Magnetic Stimulation (TMS)Respiratory Electrical Stimulation (RES)By Applications:Spinal Cord StimulationDeep Brain StimulationSacral Nerve StimulationVagus Nerve Stimulation MarketGastric Electrical StimulationTranscutaneous Electrical Nerve StimulationRepetitive Transcranial Magnetic StimulationRespiratory Electrical StimulationBy Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Rest of the World (RoW)Download Free Sample Report of Global Neuromodulation Devices Market @ https://www.decisiondatabases.com/contact/download-sample-16700The Global Neuromodulation Devices Market has been exhibited in detail in the following chapters –Chapter 1 Neuromodulation Devices Market PrefaceChapter 2 Executive SummaryChapter 3 Neuromodulation Devices Industry AnalysisChapter 4 Neuromodulation Devices Market Value Chain AnalysisChapter 5 Neuromodulation Devices Market Analysis By TechnologyChapter 6 Neuromodulation Devices Market Analysis By ApplicationsChapter 7 Neuromodulation Devices Market Analysis By GeographyChapter 8 Competitive Landscape Of Neuromodulation Devices CompaniesChapter 9 Company Profiles Of Neuromodulation Devices IndustryPurchase the complete Global Neuromodulation Devices Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16700Other Reports by DecisionDatabases.com:Global Neurostimulation Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Neurosurgical Drainage Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Neurorehabilitation System Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
BOOST YOUR BRAND EQUITY WITH DATACAPTIVE’S ENDODONTISTS EMAIL LISTIn a majority of the developing countries due to the limited access to dental healthcare, teeth are often left either untreated or are extracted as a form of relief for pain & discomfort.
This is where DataCaptive aims to bring about change.
With DataCaptive’s Endodotists Email List get connected to Top Endodontists in USA, UK, Canada etc.
& drive successful email campaigns to win leads & crack profitable deals.DataCaptive has a team of data scientists that work round the clock to put together The Endodontist Contact Database so that you can easily market your products & services to these healthcare specialists using a multichannel approach & expand your market reach significantly.Want to know more?
Contact our marketing experts now, or callContact us : 1-800-523-1387Email us : [email protected]
Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a new report by Grand View Research, Inc.
This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.Rise in incidence of cerebral stroke and other severe disorders such as Alzheimer’s disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology devices thereby driving industry growth.
According to National Institute of Neurological Disorders and Stroke (NINDS), approximately 50 million Americans are affected due to these disorders leading to high economic & disease costs burden for medical expenses coupled with loss of productivity.
The industry is expected to witness a considerable increase in demand for CNS related therapeutic procedures over the forecast period.Further key findings from the study suggest:Neurostimulation devices accounted for over 50% of the revenue generated in the market for 2014.
This large share can be attributed to the growing number of chronic CNS disorders, a globally ageing population and development of minimally invasive neurological and faster acting stimulation devices that attract higher market usage and penetration in the neurology devices market.Neurosurgery segment including ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips are expected to witness considerable growth over the forecast period due to their essential nature of use in tumor removal and brain cell damage repair surgeries.North America dominated the market in 2014, with revenue estimated at over USD 2,400 million.
Presence of sophisticated healthcare infrastructure, favorable government initiatives pertaining to pharmaceutical R, cancer research, neurological R investment, and the presence of a considerably large CNS disorder patient base are some drivers of this market.Asia Pacific is expected to witness lucrative CAGR of over 8.0% from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R investment, and growing medical expenditures in emerging economies such as India and China.
The healthcare market is growing rapidly, giving marketers an opportunity to tap new business avenues.
If you are a marketer providing services and solutions that could help the healthcare world, especially hospitals, perform their tasks with ease, APAC Leads is here to assist you!
With our database of Hospitals Email Lists, we give you the insightful data that can help you design multi-channel marketing campaigns to reach the key influencers in numerous hospitals of Asia-Pacific.
These key influencers are the professionals who can take decisions on your services or products.The professionals included in our Hospital Mailing Lists are doctors, surgeons, nurses, pathologists, and other medical professionals from numerous hospitals, such as plastic surgery hospitals, animal hospitals, psychiatric hospitals, rural hospitals, and more.
At APAC Leads, we provide you with the Hospital Email Database so that you can connect with the key decision-makers of numerous hospitals across the APAC region via email marketing successfully.
This Hospitals Email Address is available in both pre-packaged and customized formats.
Neuromodulation Market is valued around USD 4.89 Billion in 2019 and expected to reach USD 20.08 Billion by 2030 with the CAGR of 13.7% over the forecast period.Neuromodulation is a procedure which requires the implantation of electrodes directly to peripheral nerves or brain & pulse generator under skin.
This helps to provide the electrical impulses which helps in the treatment of various neurological disorders such as epilepsy, pain management, tremor and many more.
Based upon technology, the neuromodulation market is fragmented into internal neuromodulation and external neuromodulation.
Based on The regional bifurcation of countries includes North America, Europe, Asia-Pacific, and RoW which are further segmented into major countries such as U.S., UK, France, and others.The neuromodulation market is mainly driven by the high prevalence of various neurological disorders followed by the presence of large geriatric population.
There has been constant expansion of application in the treatment of various disorders followed by the growing demand for effective pain management therapies owing to growth in surgeries, trauma cases & many more.
However, high cost of the Neurostimulators along with the lack of skilled professionals trained in neuromodulation therapy is likely to inhibit the market growth during forecast period.Download sample copy of this report at https://www.nextmsc.com/Neuromodulation-Market/request-sampleThe developed regions such as North America and Europe are expected to hold the major market share owing to the presence of major market players in the region along with technological advancement.
The Global Neuromodulation Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on technology and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Neuromodulation Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/16700-neuromodulation-devices-market-reportThe report also covers the complete competitive landscape of the global Neuromodulation Devices market with company profiles of key players such as:Biocontrol MedicalBoston Scientific CorporationCyberonics, Inc.Medtronic, Inc.Neuronetics, Inc.Neuropace, Inc.Neurosigma, Inc.Nevro CorporationST.
Jude Medical, Inc.Synapse Biomedical, Inc.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Technology:Internal NeuromodulationSpinal Cord Stimulation (SCS)Deep Brain Stimulation (DBS)Vagus Nerve Stimulation (VNS)Sacral Nerve Stimulation (SNS)Gastric Electrical Stimulation (GES)External NeuromodulationTranscutaneous Electrical Nerve Stimulation (Tens)Transcranial Magnetic Stimulation (TMS)Respiratory Electrical Stimulation (RES)By Applications:Spinal Cord StimulationDeep Brain StimulationSacral Nerve StimulationVagus Nerve Stimulation MarketGastric Electrical StimulationTranscutaneous Electrical Nerve StimulationRepetitive Transcranial Magnetic StimulationRespiratory Electrical StimulationBy Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Rest of the World (RoW)Download Free Sample Report of Global Neuromodulation Devices Market @ https://www.decisiondatabases.com/contact/download-sample-16700The Global Neuromodulation Devices Market has been exhibited in detail in the following chapters –Chapter 1 Neuromodulation Devices Market PrefaceChapter 2 Executive SummaryChapter 3 Neuromodulation Devices Industry AnalysisChapter 4 Neuromodulation Devices Market Value Chain AnalysisChapter 5 Neuromodulation Devices Market Analysis By TechnologyChapter 6 Neuromodulation Devices Market Analysis By ApplicationsChapter 7 Neuromodulation Devices Market Analysis By GeographyChapter 8 Competitive Landscape Of Neuromodulation Devices CompaniesChapter 9 Company Profiles Of Neuromodulation Devices IndustryPurchase the complete Global Neuromodulation Devices Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16700Other Reports by DecisionDatabases.com:Global Neurostimulation Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Neurosurgical Drainage Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Neurorehabilitation System Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
Fight the struggles with your healthcare-related marketing campaigns with one robust database; the Medical Records Director Email List.
Respond to your market's demands instantly, with a readily available Medical Records Director Mailing List, enabling a market reach like never before.
Beat the competition in the healthcare sector with precision and through HealthExeData's on-point marketing email list.
BOOST YOUR BRAND EQUITY WITH DATACAPTIVE’S ENDODONTISTS EMAIL LISTIn a majority of the developing countries due to the limited access to dental healthcare, teeth are often left either untreated or are extracted as a form of relief for pain & discomfort.
This is where DataCaptive aims to bring about change.
With DataCaptive’s Endodotists Email List get connected to Top Endodontists in USA, UK, Canada etc.
& drive successful email campaigns to win leads & crack profitable deals.DataCaptive has a team of data scientists that work round the clock to put together The Endodontist Contact Database so that you can easily market your products & services to these healthcare specialists using a multichannel approach & expand your market reach significantly.Want to know more?
Contact our marketing experts now, or callContact us : 1-800-523-1387Email us : [email protected]
Global Nerve Repair and Regeneration Market ReportThe ‘Global Nerve Repair and Regeneration Market Insights, Forecast to 2026’ offers a comprehensive evaluation of the Nerve Repair and Regeneration market on the global scale and sheds light on the growth opportunities and prospects to help readers formulate strategic plans.
The report offers information on the overall market trends and analyzes historical data to offer accurate forecast estimations.
The report assesses the impact of the COVID-19 pandemic on the Nerve Repair and Regeneration market and key segments.
The report also studies the impact of the COVID-19 pandemic on the global supply chains and economic scenario of the industry.
It considers the COVID-19 pandemic as a key factor influencing the growth of the Nerve Repair and Regeneration market.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1733Key Manufacturers in the Global Nerve Repair and Regeneration Market:AxoGen Inc., Baxter International Inc., Boston Scientific Corporation, Livanova PLC (Cyberonics Inc.), Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Integra Lifesciences Holding Corporation, Orthod Group Ltd., Polyganics B.V., Stryker Corporation, Cyberonics Inc.The report offers an in-depth analysis of the value chain, upstream and downstream factors, sales network and distribution channels, growth trends, driving and restraining factors, developments, production and consumption pattern, end-users, and regional bifurcation.
The report also provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data.Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1733The report for the Nerve Repair and Regeneration market is formulated through the segmentation and sub-segmentation of the market to offer a better understanding of the market.
Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a new report by Grand View Research, Inc.
This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.Rise in incidence of cerebral stroke and other severe disorders such as Alzheimer’s disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology devices thereby driving industry growth.
According to National Institute of Neurological Disorders and Stroke (NINDS), approximately 50 million Americans are affected due to these disorders leading to high economic & disease costs burden for medical expenses coupled with loss of productivity.
The industry is expected to witness a considerable increase in demand for CNS related therapeutic procedures over the forecast period.Further key findings from the study suggest:Neurostimulation devices accounted for over 50% of the revenue generated in the market for 2014.
This large share can be attributed to the growing number of chronic CNS disorders, a globally ageing population and development of minimally invasive neurological and faster acting stimulation devices that attract higher market usage and penetration in the neurology devices market.Neurosurgery segment including ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips are expected to witness considerable growth over the forecast period due to their essential nature of use in tumor removal and brain cell damage repair surgeries.North America dominated the market in 2014, with revenue estimated at over USD 2,400 million.
Presence of sophisticated healthcare infrastructure, favorable government initiatives pertaining to pharmaceutical R, cancer research, neurological R investment, and the presence of a considerably large CNS disorder patient base are some drivers of this market.Asia Pacific is expected to witness lucrative CAGR of over 8.0% from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R investment, and growing medical expenditures in emerging economies such as India and China.
The polymer market is expected to progress at a 5.1% CAGR during the forecast period (2020–2030) owing to the increasing substitution of conventional materials in the automotive industry with lighter alternatives and escalating use of smart polymers in the healthcare sector.
Additionally, polymers are also used in large quantities in the packaging and electronics industries.
These drivers will, therefore, help the market grow from $533.6 billion in 2019 to $838.5 billion by 2030.The growing preference for lightweight materials in the automobile and other manufacturing industries will play a vital role in the polymer market growth.
These sectors are using polymers as a substitute for conventional materials like metals and ceramics, as the former have excellent electrical, chemical, and mechanical properties, such as corrosion resistance, elasticity, high strength-to-weight ratio, and insulating and optical properties.
Moreover, it is estimated that a nearly 10% reduction in vehicle weight causes a proportional reduction in fuel consumption.Another key factor accelerating the polymer market growth is the increasing usage of smart polymers in the healthcare industry.
The mushrooming demand for hydrogels (for targeted drug delivery), biosensors, and artificial body parts will fuel the demand for such polymers in the coming years.
The healthcare market is growing rapidly, giving marketers an opportunity to tap new business avenues.
If you are a marketer providing services and solutions that could help the healthcare world, especially hospitals, perform their tasks with ease, APAC Leads is here to assist you!
With our database of Hospitals Email Lists, we give you the insightful data that can help you design multi-channel marketing campaigns to reach the key influencers in numerous hospitals of Asia-Pacific.
These key influencers are the professionals who can take decisions on your services or products.The professionals included in our Hospital Mailing Lists are doctors, surgeons, nurses, pathologists, and other medical professionals from numerous hospitals, such as plastic surgery hospitals, animal hospitals, psychiatric hospitals, rural hospitals, and more.
At APAC Leads, we provide you with the Hospital Email Database so that you can connect with the key decision-makers of numerous hospitals across the APAC region via email marketing successfully.
This Hospitals Email Address is available in both pre-packaged and customized formats.
Buddhi Clinic is best Brain Mapping Nerve Conduction Centre in Chennai.
Our Neurologists diagnosing, treating, and managing disorders of the brain and nervous system.Brain Mapping Labs in Chennai